Clinical Trials Browser

Phase 2 × NIH × HER2 peptide (369-377) × Clear all

NCT02636582 2023-12-05

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

Phase 2 Completed

43 enrolled 10 charts

Carcinoma, Intraductal, Noninfiltrating